Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysisFrançois‐Clément Bidard, Paul Cottu, Daniele Generali et al.|JNCI Journal of the National Cancer Institute|2018Cited by 282
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Klaus Pantel, Jean‐Yves Pierga et al.|Critical Reviews in Oncology/Hematology|2018Cited by 268
Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: A phase II multicentric studyEduardo Díaz‐Rubio, M. Homerin, Javier Sastre et al.|Annals of Oncology|1998Cited by 228
Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the UrotheliumJoaquim Bellmunt, Vicente Guillém, Luis Paz‐Ares et al.|Journal of Clinical Oncology|2000Cited by 191
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trialJ Cassidy, L. Garrison, J.-Y. Douillard et al.|British Journal of Cancer|2006Cited by 125